Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

15.72 -0.27 (-1.69%)
Streaming Delayed Price Updated: 12:07 PM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Beta Bionics, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print 
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
From Robbins LLP
Via Business Wire
News headline image
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Present at the Bank of America Securities Health Care Conference
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
Advanced report intelligence delivers actionable guidance to improve outcomes for people using the iLet Bionic Pancreas 
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
BBNX SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX
From Pomerantz LLP
Via GlobeNewswire
News headline image
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX
From Pomerantz LLP
Via GlobeNewswire
News headline image
BBNX FRAUD INVESTIGATION: Kaplan Fox Alerts Investors of Beta Bionics, Inc. (BBNX) to Potential Securities Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud
News headline image
BBNX FRAUD INVESTIGATION: Kaplan Fox Alerts Investors of Beta Bionics, Inc. (BBNX) to Potential Securities Violations
NEW YORK, NY - January 23, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Fraud
News headline image
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Kaplan Fox Reminds Investors of Beta Bionics, Inc. (BBNX) to an Investigation of Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kaplan Fox Reminds Investors of Beta Bionics, Inc. (BBNX) to an Investigation of Potential Securities Law Violations
NEW YORK, NY - January 22, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.